| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $15,190,024 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 000 | 18 | NIH | 11/2/2023 | $466,601 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U2CEB032224 | eLwazi Open Data Science Platform and Coordinating Center | 001 | 4 | NIH | 9/9/2024 | $107,568 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW012864 | Bifidobacterium infantis supplementation in early life to improve neurodevelopment in infants exposed to HIV | 000 | 1 | NIH | 8/15/2024 | $51,762 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW012864 | Bifidobacterium infantis supplementation in early life to improve neurodevelopment in infants exposed to HIV | 000 | 1 | NIH | 8/15/2024 | $50,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01MH131022 | Early brain development in children born to depressed mothers in high and low income settings | 001 | 3 | NIH | 7/10/2024 | $364,596 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW012887 | Metabolomic predictors of weight gain during pregnancy and the postpartum period in South African women living with HIV | 000 | 1 | NIH | 8/23/2024 | $113,048 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW012840 | Developing a suicide prevention intervention for people with HIV in South Africa | 000 | 1 | NIH | 8/15/2024 | $63,240 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW012840 | Developing a suicide prevention intervention for people with HIV in South Africa | 000 | 1 | NIH | 8/15/2024 | $50,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U2RTW012131 | Computational Omics and Biomedical Informatics Program (COBIP) | 000 | 4 | NIH | 7/30/2024 | $1 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U2RTW012131 | Computational Omics and Biomedical Informatics Program (COBIP) | 000 | 4 | NIH | 7/30/2024 | $249,507 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U2RTW012131 | Computational Omics and Biomedical Informatics Program (COBIP) | 000 | 4 | NIH | 7/30/2024 | $100,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D43TW011950 | Program ARISE2: African mental health Researchers Inspired and Equipped | 000 | 4 | NIH | 7/18/2024 | $185,445 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R33DA053736 | Cape Town Adolescent Antiretroviral Cohort- Substance, Imaging, Mental Health (CTAAC-SIM) | 001 | 4 | NIH | 8/8/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R33DA053736 | Cape Town Adolescent Antiretroviral Cohort- Substance, Imaging, Mental Health (CTAAC-SIM) | 000 | 4 | NIH | 7/16/2024 | $470,988 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R21HD114232 | Functional longevity of maternally derived antibodies against group B Streptococcus and respiratory syncytial virus in HIV-exposed uninfected and HIV-unexposed uninfected infants. | 000 | 1 | NIH | 1/11/2024 | $150,257 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01TW012626 | INnovative data Science to Impact the TB Epidemic - INSITE | 001 | 2 | NIH | 5/6/2024 | $1 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01TW012626 | INnovative data Science to Impact the TB Epidemic - INSITE | 001 | 2 | NIH | 5/6/2024 | $249,735 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW012587 | Insulin-like Growth Factor-1 (IGF-1) signalling in immunometabolism of TB and TB-Diabetes comorbidity | 000 | 2 | NIH | 4/4/2024 | $112,504 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D71TW012568 | Developing an in vivo infectious disease training program at the University of Cape Town | 000 | 2 | NIH | 6/5/2024 | $108,226 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U24HG012750 | African Genomics Data Hub Biomedical Knowledgebase | 000 | 2 | NIH | 6/21/2024 | $561,795 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01MH132950 | 3/3 Akili: Phenotypic and genetic characterization of ADHD in Kenya and South Africa | 000 | 2 | NIH | 6/12/2024 | $523,633 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R21HD110305 | Influence of fetal antiretroviral exposure on gut microbiota, systemic inflammation and neurodevelopment in infants exposed to HIV | 000 | 2 | NIH | 2/9/2024 | $140,547 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R25TW012219 | Establishing an MSc in Global Health Ethics at the University of Cape Town | 000 | 3 | NIH | 3/23/2024 | $208,798 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R34MH126702 | Building Resources to Achieve Improvement in Neurocognition (B.R.A.I.N.) inpeople with HIV. | 000 | 3 | NIH | 7/11/2024 | $104,662 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D71TW012504 | A Training Development Plan for HIV-associated Behavioural Medicine | 000 | 2 | NIH | 1/29/2024 | $5,240 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D71TW012504 | A Training Development Plan for HIV-associated Behavioural Medicine | 000 | 2 | NIH | 1/29/2024 | $25,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01MH127692 | Public Understanding of Big data in Genomics Medicine in Africa (PUBGEM-Africa) | 000 | 4 | NIH | 8/27/2024 | $100,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01MH127692 | Public Understanding of Big data in Genomics Medicine in Africa (PUBGEM-Africa) | 000 | 4 | NIH | 8/27/2024 | $286,254 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01MH125053 | 3/3 Genomics of Schizophrenia in the South African Xhosa | 001 | 4 | NIH | 7/16/2024 | $77,292 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01MH125053 | 3/3 Genomics of Schizophrenia in the South African Xhosa | 000 | 4 | NIH | 3/1/2024 | $695,638 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011943 | Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa | 001 | 4 | NIH | 9/5/2024 | $95,404 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011943 | Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa | 000 | 4 | NIH | 5/6/2024 | $54,642 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011943 | Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa | 000 | 4 | NIH | 5/6/2024 | $50,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI160501 | Targeting non-coding RNAs as host-directed drug therapy for tuberculosis | 000 | 4 | NIH | 4/10/2024 | $131,718 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI150850 | Durability of systemic and lung immune correlates of BCG-induced protection against M. tuberculosis infection | 000 | 4 | NIH | 8/16/2024 | $593,748 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152118 | Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate. | 002 | 5 | NIH | 5/2/2024 | $310,310 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152118 | Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate. | 002 | 5 | NIH | 5/2/2024 | $150,720 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152118 | Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate. | 002 | 5 | NIH | 5/2/2024 | $192,500 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152183 | Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study) | 003 | 4 | NIH | 7/15/2024 | $127,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152183 | Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study) | 003 | 4 | NIH | 7/15/2024 | -$127,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152183 | Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study) | 002 | 4 | NIH | 4/18/2024 | $192,378 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152183 | Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study) | 002 | 4 | NIH | 4/18/2024 | $127,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152115 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa | 002 | 5 | NIH | 3/28/2024 | $48,126 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152115 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa | 002 | 5 | NIH | 3/28/2024 | $279,512 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01CA250011 | Automated Visual Evaluation for Cervical Cancer Screening in HIV-positive Women | 001 | 5 | NIH | 8/8/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01CA250011 | Automated Visual Evaluation for Cervical Cancer Screening in HIV-positive Women | 001 | 5 | NIH | 8/8/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01CA250011 | Automated Visual Evaluation for Cervical Cancer Screening in HIV-positive Women | 000 | 5 | NIH | 5/1/2024 | $132,516 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01CA250011 | Automated Visual Evaluation for Cervical Cancer Screening in HIV-positive Women | 000 | 5 | NIH | 5/1/2024 | $191,326 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152092 | Repurposing kinase inhibitor chemotypes as antimalarials | 001 | 5 | NIH | 4/11/2024 | $178,500 |
|
